Results 81 to 90 of about 1,101 (163)

ePosters

open access: yes
European Journal of Neurology, Volume 31, Issue S1, June 2024.
wiley   +1 more source

Two common mutations (p.Gln832X and c.663+1G>C) account for about a third of the DYSF mutations in Korean patients with dysferlinopathy

open access: yes, 2012
Dysferlinopathy refers to autosomal recessive muscular dystrophies caused by mutations in dysferlin gene (DYSF). It includes two major distinct disorders, Miyoshi myopathy and limb-girdle muscular dystrophy type 2B.
최영철
core   +1 more source

Abstracts

open access: yes
Cancer Science, Volume 115, Issue S1, Page 1-2243, March 2024.
wiley   +1 more source

Calf-head sign in miyoshi myopathy

open access: yes
Objective To observe whether patients with Miyoshi-type dysferlinopathy demonstrate any distinct appearance in the back of the shoulders and upper back in a specific posture. Design Case series.
Pradhan, Sunil.
core  

Modeling and gene therapy of dysferlinopathy [PDF]

open access: yes, 2013
Dysferlinopathies is a group of autosomal-recessive inherited neuromuscular diseases, which are characterized by defect in mRNA expression or in functionioning of dysferlin protein, appearing in about 1/200 000 births.
Solovyeva V.   +7 more
core  

Identical mutation in patients with limb girdle muscular dystrophy type 2B or Miyoshi myopathy suggests a role for modifier gene(s)

open access: yes, 1999
Limb girdle muscular dystrophy type 2B (LGMD2B) and Miyoshi myopathy (MM), a distal muscular dystrophy, are both caused by mutations in the recently cloned gene dysferlin, gene symbol DYSF. Two large pedigrees have been described which have both types of
Vafiadaki E   +11 more
core  

Correction: Efficient and Reproducible Myogenic Differentiation from Human iPS Cells: Prospects for Modeling Miyoshi Myopathy.

open access: yesPLoS ONE, 2013
Akihito Tanaka   +16 more
doaj   +1 more source

Full-Length Dysferlin Expression Driven by Engineered Human Dystrophic Blood-Derived CD133+ Stem Cells

open access: yes, 2014
The protein dysferlin is abundantly expressed in skeletal and cardiac muscles, where its main function is membrane repair. Mutations in the dysferlin gene are involved in two autosomal recessive muscular dystrophies: Miyoshi myopathy and limb-girdle ...
D. Parazzoli   +8 more
core  

Modeling and gene therapy of dysferlinopathy

open access: yes, 2020
Dysferlinopathies is a group of autosomal-recessive inherited neuromuscular diseases, which are characterized by defect in mRNA expression or in functionioning of dysferlin protein, appearing in about 1/200 000 births.
Solovyeva V.   +7 more
core  

Home - About - Disclaimer - Privacy